Background Several novel treatments targeting the calcitonin gene-related peptide pathway
have been developed for migraine. We evaluated the efficacy of these medications …

Migraine is a severe neurovascular disorder of which the pathophysiology is not yet fully
understood. Besides the role of inflammatory mediators that interact with the …

Introduction Migraine prophylactic therapy has changed over recent years with the
development and approval of monoclonal antibodies (mAbs) targeting the calcitonin gene …

The monoclonal antibodies (mAbs) blocking the calcitonin-gene related peptide (CGRP)
pathway, collectively called here “anti-CGRP/rec mAbs”, have dramatically improved …

Migraine is the most common neurological disorder in the world, affecting 12% of the
population. Migraine involves the central nervous system, trigeminal nerves and meninges …

Migraine is a disabling neurovascular disorder, characterized by moderate to severe
unilateral headaches, nausea, photophobia, and/or phonophobia, with a higher prevalence …

Migraine is an incapacitating neurological disorder that predominantly affects women. Sex
and other hormones (eg, oxytocin, and prolactin) may play a role in sexual dimorphic …

Migraine is a leading cause of disability among the adult population and is a significant
burden on the economies of the world. Studies into the underlying causes of migraine have …

Objective This narrative review of the literature concerns persistent headache attributed to
past non‐traumatic subarachnoid hemorrhage (SAH), based off demographic and clinical …

Migraine is a neurovascular disorder that is three times more prevalent in women than in
men and represents a large socio-economic burden. Therefore, the development of new …